Biotech IPOs in Hong Kong far outpace the US, driven by China’s buzzy biotech sector
As biotech IPOs hit a record low in the US, more than 40 Chinese biopharma companies have filed to go public so far this year … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. Source link
